Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia.

Woo J, Choi DR, Storer BE, Yeung C, Halpern AB, Salit RB, Sorror ML, Woolston DW, Monahan T, Scott BL, Deeg HJ.

Haematologica. 2019 Jul 9. pii: haematol.2019.218677. doi: 10.3324/haematol.2019.218677. [Epub ahead of print]

2.

Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis.

Salit RB, Scott BL, Stevens EA, Baker KK, Gooley TA, Deeg HJ.

Bone Marrow Transplant. 2019 Apr 8. doi: 10.1038/s41409-019-0523-3. [Epub ahead of print]

PMID:
30962501
3.

Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.

Elsawy M, Storer BE, Milano F, Sandmaier BM, Delaney C, Salit RB, Rashad AH, Woolfrey AE, Appelbaum FR, Storb R, Sorror ML.

Biol Blood Marrow Transplant. 2019 May;25(5):1045-1052. doi: 10.1016/j.bbmt.2018.11.030. Epub 2018 Nov 28.

PMID:
30500442
4.

Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation.

Fatobene G, Storer BE, Salit RB, Lee SJ, Martin PJ, Cheng GS, Carpenter PA, Balgansuren G, Petersdorf EW, Delaney C, Sandmaier BM, Milano F, Flowers ME.

Haematologica. 2019 Apr;104(4):835-843. doi: 10.3324/haematol.2018.202754. Epub 2018 Nov 15.

5.

Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR).

Bhatt NS, Brazauskas R, Tecca HR, Carreras J, Burns LJ, Phelan R, Salit RB, Syrjala KL, Talano JM, Shaw BE.

Cancer. 2019 Jan 1;125(1):144-152. doi: 10.1002/cncr.31781. Epub 2018 Oct 12.

PMID:
30368771
6.

Rates and Risk Factors for Post-Traumatic Stress Disorder Symptomatology among Adult Hematopoietic Cell Transplant Recipients and Their Informal Caregivers.

Liang J, Lee SJ, Storer BE, Shaw BE, Chow EJ, Flowers ME, Krakow EF, Bar M, Syrjala KL, Salit RB, Kurukulasuriya CE, Jim HSL.

Biol Blood Marrow Transplant. 2019 Jan;25(1):145-150. doi: 10.1016/j.bbmt.2018.08.002. Epub 2018 Aug 9.

PMID:
30098393
7.

Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients.

Jamani K, Onstad LE, Bar M, Carpenter PA, Krakow EF, Salit RB, Flowers MED, Lee SJ.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2271-2276. doi: 10.1016/j.bbmt.2018.06.015. Epub 2018 Jun 21.

PMID:
29935213
8.

Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.

Deeg HJ, Stevens EA, Salit RB, Ermoian RP, Fang M, Gyurkocza B, Sorror ML, Fatobene G, Baumgart J, Burroughs LM, Delaney C, Doney K, Egan DN, Flowers MED, Milano F, Radich JP, Scott BL, Sickle EJ, Wood BL, Yeung C, Storer BE.

Biol Blood Marrow Transplant. 2018 May;24(5):956-963. doi: 10.1016/j.bbmt.2017.12.785. Epub 2017 Dec 20.

9.

Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease.

Lee SJ, Nguyen TD, Onstad L, Bar M, Krakow EF, Salit RB, Carpenter PA, Rodrigues M, Hall AM, Storer BE, Martin PJ, Flowers ME.

Biol Blood Marrow Transplant. 2018 Mar;24(3):555-562. doi: 10.1016/j.bbmt.2017.10.042. Epub 2017 Nov 10.

10.

Transplant Decisions in Patients with Myelofibrosis: Should Mutations Be the Judge?

Salit RB, Deeg HJ.

Biol Blood Marrow Transplant. 2018 Apr;24(4):649-658. doi: 10.1016/j.bbmt.2017.10.037. Epub 2017 Nov 8. Review.

11.

Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.

Samuelson Bannow BT, Salit RB, Storer BE, Stevens EA, Wu D, Yeung C, Fang M, Petersdorf EW, Linenberger ML, Woo J, Sorror ML, Doney K, Sandmaier BM, Deeg HJ, Scott BL.

Biol Blood Marrow Transplant. 2018 Feb;24(2):386-392. doi: 10.1016/j.bbmt.2017.09.016. Epub 2017 Sep 29.

12.

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.

Bashey A, Zhang MJ, McCurdy SR, St Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M, Munshi P, Al Malki MM, Nakamura R, O'Donnell PV, Perales MA, Raj K, Romee R, Rowley S, Rocha V, Salit RB, Solh M, Soiffer RJ, Fuchs EJ, Eapen M.

J Clin Oncol. 2017 Sep 10;35(26):3002-3009. doi: 10.1200/JCO.2017.72.8428. Epub 2017 Jun 23. Erratum in: J Clin Oncol. 2019 Feb 20;37(6):528.

13.

Prognostic Value of the Hematopoietic Cell Transplantation Comorbidity Index for Patients Undergoing Reduced-Intensity Conditioning Cord Blood Transplantation.

Salit RB, Oliver DC, Delaney C, Sorror ML, Milano F.

Biol Blood Marrow Transplant. 2017 Apr;23(4):654-658. doi: 10.1016/j.bbmt.2017.01.084. Epub 2017 Feb 9.

14.

Publish or perish: can a 'Write Club' help junior faculty be more productive?

Lee SJ, Cheng GS, Hyun TS, Salit RB, Loggers ET, Egan D, Shadman M, Connelly-Smith L, Krakow EF, Flowers ME.

Bone Marrow Transplant. 2017 Mar;52(3):489-490. doi: 10.1038/bmt.2016.314. Epub 2016 Dec 12. No abstract available.

PMID:
27941779
15.

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

Ghosh N, Karmali R, Rocha V, Ahn KW, DiGilio A, Hari PN, Bachanova V, Bacher U, Dahi P, de Lima M, D'Souza A, Fenske TS, Ganguly S, Kharfan-Dabaja MA, Prestidge TD, Savani BN, Smith SM, Sureda AM, Waller EK, Jaglowski S, Herrera AF, Armand P, Salit RB, Wagner-Johnston ND, Fuchs E, Bolaños-Meade J, Hamadani M.

J Clin Oncol. 2016 Sep 10;34(26):3141-9. doi: 10.1200/JCO.2015.66.3476. Epub 2016 Jun 6.

16.

Outcomes of Cord Blood Transplantation as Salvage Therapy after Graft Failure or Relapse after Prior Allogeneic Transplantation.

Salit RB, Milano F, Delaney C.

Biol Blood Marrow Transplant. 2016 Feb;22(2):339-343. doi: 10.1016/j.bbmt.2015.10.013. Epub 2015 Oct 17.

17.

Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantation.

Rosenberg AR, Syrjala KL, Martin PJ, Flowers ME, Carpenter PA, Salit RB, Baker KS, Lee SJ.

Cancer. 2015 Dec 1;121(23):4250-7. doi: 10.1002/cncr.29651. Epub 2015 Aug 19.

18.

Role of hematopoietic stem cell transplantation in patients with myeloproliferative disease.

Salit RB, Deeg HJ.

Hematol Oncol Clin North Am. 2014 Dec;28(6):1023-35. doi: 10.1016/j.hoc.2014.08.003. Epub 2014 Oct 3. Review.

19.

Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.

Elinoff JM, Bagci U, Moriyama B, Dreiling JL, Foster B, Gormley NJ, Salit RB, Cai R, Sun J, Beri A, Reda DJ, Fakhrejahani F, Battiwalla M, Baird K, Cuellar-Rodriguez JM, Kang EM, Pavletic SZ, Fowler DH, John Barrett A, Lozier JN, Kleiner DE Jr, Mollura DJ, Childs RW, Suffredini AF.

Biol Blood Marrow Transplant. 2014 Jul;20(7):969-78. doi: 10.1016/j.bbmt.2014.03.015. Epub 2014 Mar 20.

20.

Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation.

Salit RB, Fowler DH, Dean RM, Pavletic SZ, Hakim FT, Steinberg SM, Hardy NT, Sportes C, Gress RE, Bishop MR.

Biol Blood Marrow Transplant. 2013 Oct;19(10):1509-13. doi: 10.1016/j.bbmt.2013.08.001. Epub 2013 Aug 13.

21.

Successful sirolimus graded dose challenge in an erythromycin-allergic patient.

Leiding JW, Hughes T, Chasick A, Salit RB.

Ann Allergy Asthma Immunol. 2012 Oct;109(4):284-5. doi: 10.1016/j.anai.2012.07.027. Epub 2012 Aug 15. No abstract available. Erratum in: Ann Allergy Asthma Immunol. 2012 Dec;109(6):476. Chasik, Ashley [corrected to Chasick, Ashley].

PMID:
23010239
22.

Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.

Salit RB, Fowler DH, Wilson WH, Dean RM, Pavletic SZ, Dunleavy K, Hakim F, Fry TJ, Steinberg SM, Hughes TE, Odom J, Bryant K, Gress RE, Bishop MR.

J Clin Oncol. 2012 Mar 10;30(8):830-6. doi: 10.1200/JCO.2011.37.0296. Epub 2012 Feb 6. Erratum in: J Clin Oncol. 2012 May 1;30(13):1570. Dosage error in article text.

23.

Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity.

Grkovic L, Baird K, Steinberg SM, Williams KM, Pulanic D, Cowen EW, Mitchell SA, Hakim FT, Martires KJ, Avila DN, Taylor TN, Salit RB, Rowley SD, Zhang D, Fowler DH, Bishop MR, Gress RE, Pavletic SZ.

Leukemia. 2012 Apr;26(4):633-43. doi: 10.1038/leu.2011.254. Epub 2011 Oct 18.

24.

The tumor lysis syndrome.

Elinoff JM, Salit RB, Ackerman HC.

N Engl J Med. 2011 Aug 11;365(6):571-2; author reply 573-4. doi: 10.1056/NEJMc1106641. No abstract available. Erratum in: N Engl J Med. 2011 Oct 27;365(17):1650.

25.

Reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma: a concise review.

Salit RB, Bishop MR.

Clin Lymphoma Myeloma Leuk. 2011 Jun;11(3):247-52. doi: 10.1016/j.clml.2011.03.010. Epub 2011 Apr 20. Review.

PMID:
21658650
26.

The evolving world of tumor lysis syndrome.

Salit RB, Bishop MR.

Oncology (Williston Park). 2011 Apr 15;25(4):378, 380. Review. No abstract available.

27.

Death by edible mushroom: first report of Volvariella volvacea as an etiologic agent of invasive disease in a patient following double umbilical cord blood transplantation.

Salit RB, Shea YR, Gea-Banacloche J, Fahle GA, Abu-Asab M, Sugui JA, Carpenter AE, Quezado MM, Bishop MR, Kwon-Chung KJ.

J Clin Microbiol. 2010 Nov;48(11):4329-32. doi: 10.1128/JCM.01222-10. Epub 2010 Sep 8.

28.

Allogeneic hematopoietic stem cell transplantation: does it have a place in treating Hodgkin lymphoma?

Salit RB, Bishop MR, Pavletic SZ.

Curr Hematol Malig Rep. 2010 Oct;5(4):229-38. doi: 10.1007/s11899-010-0065-7. Review.

PMID:
20730513
29.

Detection of CD4(+) T-cell antibodies in a patient with idiopathic CD4 T lymphocytopenia and cryptococcal meningitis.

Salit RB, Hankey KG, Yi R, Rapoport AP, Mann DL.

Br J Haematol. 2007 Oct;139(1):133-7.

PMID:
17854318
30.

Ins and outs of clinical trials with peptide-based vaccines.

Salit RB, Kast WM, Velders MP.

Front Biosci. 2002 May 1;7:e204-13. Review.

PMID:
11991853
31.

Burkitt's/Burkitt's-like lymphoma presenting as bacterial sinusitis in two HIV-infected children.

Robinson MR, Salit RB, Bryant-Greenwood PK, Zeichner SL, Wood LV, Jaffe ES, van Waes C, Magrath IT.

AIDS Patient Care STDS. 2001 Sep;15(9):453-8.

PMID:
11587630

Supplemental Content

Loading ...
Support Center